78
Views
14
CrossRef citations to date
0
Altmetric
Review

Profile of aclidinium bromide in the treatment of chronic obstructive pulmonary disease

&
Pages 457-466 | Published online: 16 Sep 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Emily M. Armstrong, Bradley M. Wright, Allison Meyer, Courtney S. Watts & Kristi W. Kelley. (2014) The Role of Aclidinium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease. Hospital Practice 42:4, pages 99-110.
Read now
Amir Sharafkhaneh, Hashir Majid & Nicholas J Gross. (2013) Safety and tolerability of inhalational anticholinergics in COPD. Drug, Healthcare and Patient Safety 5, pages 49-55.
Read now
Roland Buhl & Donald Banerji. (2012) Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD. International Journal of Chronic Obstructive Pulmonary Disease 7, pages 729-741.
Read now

Articles from other publishers (11)

A. G. Chuchalin, S. N. Avdeev, Z. R. Aisanov, A. S. Belevskiy, I. V. Leshchenko, S. I. OvcharenkoE. I. Shmelev. (2022) Federal guidelines on diagnosis and treatment of chronic obstructive pulmonary disease. PULMONOLOGIYA 32:3, pages 356-392.
Crossref
Ruxandra Ulmeanu, Ariadna Petronela Fildan, Ruxandra Mioara Rajnoveanu, Ovidiu Fira-Mladinescu, Claudia Toma, Roxana Maria Nemes, Emanuela Tudorache, Cristian Oancea & Florin Mihaltan. (2020) Romanian clinical guideline for diagnosis and treatment of COPD. Journal of International Medical Research 48:8, pages 030006052094690.
Crossref
Han Ni, Soe Moe, Zay Soe, Kay Thi Myint & K Neelakantan Viswanathan. (2018) Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD). Cochrane Database of Systematic Reviews 2018:12.
Crossref
K. Suresh Babu & Jaymin B. Morjaria. (2015) Clinicopharmacological profile of the fixed-dose combination of aclidinium bromide and formoterol fumarate in the management of chronic obstructive pulmonary disease. Therapeutic Advances in Respiratory Disease 9:2, pages 56-68.
Crossref
Hannu Kankaanranta, Terttu Harju, Maritta Kilpeläinen, Witold Mazur, Juho T. Lehto, Milla Katajisto, Timo Peisa, Tuula Meinander & Lauri Lehtimäki. (2015) Diagnosis and Pharmacotherapy of Stable Chronic Obstructive Pulmonary Disease: The Finnish Guidelines. Basic & Clinical Pharmacology & Toxicology 116:4, pages 291-307.
Crossref
Han Ni, Zay Soe & Soe Moe. (2014) Aclidinium bromide for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2015:4.
Crossref
Han Ni, Zay Soe & Soe Moe. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Debra J. ReidNga T. Pham. (2013) Emerging Therapeutic Options for the Management of COPD. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 7, pages CCRPM.S8140.
Crossref
Marc Decramer, François Maltais, Gregory Feldman, Jean Brooks, Stephanie Harris, Rashmi Mehta & Glenn Crater. (2013) Bronchodilation of umeclidinium, a new long-acting muscarinic antagonist, in COPD patients. Respiratory Physiology & Neurobiology 185:2, pages 393-399.
Crossref
Uwe Fricke & Ulrich Schwabe. 2013. Arzneiverordnungs-Report 2013. Arzneiverordnungs-Report 2013 47 120 .
Garbo Mak & Nicola A Hanania. (2012) New bronchodilators. Current Opinion in Pharmacology 12:3, pages 238-245.
Crossref